Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation and protects rats from spinal cord injury-induced acute lung injury.
about
Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationshipNanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury.Potential immunotherapies for traumatic brain and spinal cord injury.miRNA-146a attenuates inflammation in an spinal cord injury model via inhibition of TLR4 signaling
P2860
Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation and protects rats from spinal cord injury-induced acute lung injury.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Dopamine D1 receptor agonist A ...... ury-induced acute lung injury.
@en
Dopamine D1 receptor agonist A ...... ury-induced acute lung injury.
@nl
type
label
Dopamine D1 receptor agonist A ...... ury-induced acute lung injury.
@en
Dopamine D1 receptor agonist A ...... ury-induced acute lung injury.
@nl
prefLabel
Dopamine D1 receptor agonist A ...... ury-induced acute lung injury.
@en
Dopamine D1 receptor agonist A ...... ury-induced acute lung injury.
@nl
P2093
P2860
P356
P1433
P1476
Dopamine D1 receptor agonist A ...... ury-induced acute lung injury.
@en
P2093
P2860
P2888
P304
P356
10.1038/SC.2016.52
P577
2016-04-12T00:00:00Z